Published in Nucl Med Biol on October 27, 2010
¹⁸F-FDG uptake by spleen helps rapidly predict the dose level after total body irradiation in a Tibetan minipig model. Eur Radiol (2012) 0.82
Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake? Eur Radiol (2015) 0.82
Imaging malignant melanoma with (18)F-5-FPN. Eur J Nucl Med Mol Imaging (2015) 0.81
Liver standardized uptake value corrected for lean body mass at FDG PET/CT: effect of FDG uptake time. Clin Nucl Med (2015) 0.81
Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes. Cardiovasc Diabetol (2015) 0.80
Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation. World J Gastroenterol (2014) 0.77
Impacts of biological and procedural factors on semiquantification uptake value of liver in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging. Quant Imaging Med Surg (2015) 0.75
Factors That Affect PERCIST-Defined Test-Retest Comparability: An Exploration of Feasibility in Routine Clinical Practice. Clin Nucl Med (2015) 0.75
Predictive significance of standardized uptake value parameters of FDG-PET in patients with non-small cell lung carcinoma. Braz J Med Biol Res (2015) 0.75
Concurrent Low Brain and High Liver Uptake on FDG PET Are Associated with Cardiovascular Risk Factors. Korean J Radiol (2017) 0.75
Implications of Ambient Glucose Variation on the Target-to-Background Ratio of Hepatic Tumors By (18)FDG-PET Imaging. J Clin Imaging Sci (2014) 0.75
Effect of hyperglycemia on brain and liver (18)F-FDG standardized uptake value (FDG SUV) measured by quantitative positron emission tomography (PET) imaging. Biomed Pharmacother (2017) 0.75
Radiation exposure and risk-benefit analysis in cancer screening using FDG-PET: results of a Japanese nationwide survey. Ann Nucl Med (2011) 1.95
[18F]Fluorodeoxyglucose-PET/CT differentiation between physiological and pathological accumulations in head and neck. Nucl Med Commun (2009) 1.59
A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet (2012) 1.58
Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys (2009) 1.56
Regulation of the PRL promoter by Akt through cAMP response element binding protein. Endocrinology (2002) 1.51
Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem (2004) 1.50
Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging (2005) 1.45
Diagnostic usefulness of 18F-FDG PET/CT in the differentiation of pulmonary artery sarcoma and pulmonary embolism. Ann Nucl Med (2009) 1.42
Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel. J Biol Chem (2002) 1.41
Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening. Ann Nucl Med (2013) 1.41
Occurrence of fetal choroid plexus cysts in siblings: concerns regarding recurrence and chromosomal abnormality. J Obstet Gynaecol Res (2005) 1.40
Determination of the depth of 50% of maximum ionization, I50, for electron beams by the divided difference method. Med Phys (2004) 1.39
Deaths within 12 months after (125)I implantation for brachytherapy of prostate cancer: an investigation of radiation safety issues in Japan (2003-2010). Brachytherapy (2011) 1.38
Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho. Cancer Res (2002) 1.35
A1C but not serum glycated albumin is elevated in late pregnancy owing to iron deficiency. Diabetes Care (2008) 1.35
Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells. J Endocrinol (2004) 1.24
Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervix. Lab Invest (2003) 1.23
MR imaging of an atypical vaginal leiomyoma. AJR Am J Roentgenol (2002) 1.17
Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Ann Nucl Med (2009) 1.13
Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene (2004) 1.13
Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course. BMC Cancer (2012) 1.13
Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Mod Rheumatol (2011) 1.10
Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer. Cancer Res (2005) 1.10
FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med (2011) 1.09
A case of disseminated peritoneal leiomyomatosis developing after laparoscope-assisted myomectomy. Gynecol Obstet Invest (2008) 1.06
Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Clin Cancer Res (2004) 1.06
Mouse model of human infertility: transient and local inhibition of endometrial STAT-3 activation results in implantation failure. FEBS Lett (2006) 1.05
Utility of F-18 FDG PET/CT in screening for paraneoplastic neurological syndromes. Clin Nucl Med (2012) 1.02
Whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography images before and after chemotherapy for Kaposi sarcoma and highly active antiretrovirus therapy. Jpn J Radiol (2010) 1.02
Kikuchi disease: 18F-FDG positron emission tomography/computed tomography of lymph node uptake. Jpn J Radiol (2010) 1.02
Japanese structure survey of radiation oncology in 2005 based on institutional stratification of patterns of care study. Int J Radiat Oncol Biol Phys (2008) 1.01
Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin. Endocrinology (2003) 1.01
Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica. Mod Rheumatol (2014) 1.01
Assessment of therapeutic tumor response using 99mtc-ethylenedicysteine-glucosamine. Cancer Biother Radiopharm (2004) 1.00
Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. Mol Ther (2002) 1.00
Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer (2002) 0.99
Neck node metastasis after successful brachytherapy for early stage tongue carcinoma. Radiother Oncol (2003) 0.99
Mechanisms of platinum drug resistance. Trends Pharmacol Sci (2005) 0.99
MRI, MR spectroscopy, and diffusion tensor imaging findings in patient with static encephalopathy of childhood with neurodegeneration in adulthood (SENDA). Brain Dev (2012) 0.98
A meta-analysis of (18)F-Fluoride positron emission tomography for assessment of metastatic bone tumor. Ann Nucl Med (2010) 0.98
Brachytherapy of stage II mobile tongue carcinoma. Prediction of local control and QOL. Radiat Oncol (2006) 0.97
Expression and regulation of 4F2hc and hLAT1 in human trophoblasts. Am J Physiol Cell Physiol (2002) 0.97
Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma. Ann Nucl Med (2014) 0.96
Brain perfusion asymmetry in patients with oral somatic delusions. Eur Arch Psychiatry Clin Neurosci (2013) 0.96
RhoA/Rho-kinase cascade is involved in oxytocin-induced rat uterine contraction. Endocrinology (2002) 0.95
Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT. Nucl Med Biol (2006) 0.94
Hypoxia up-regulates hypoxia-inducible factor-1alpha expression through RhoA activation in trophoblast cells. J Clin Endocrinol Metab (2004) 0.93
Regional cerebral blood flow in depressed patients with white matter magnetic resonance hyperintensity. Biol Psychiatry (2003) 0.93
Japanese structure survey of radiation oncology in 2007 based on institutional stratification of patterns of care study. Int J Radiat Oncol Biol Phys (2010) 0.93
FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT. Ann N Y Acad Sci (2011) 0.92
Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin. Cancer Lett (2006) 0.92
(18)F-FDG-PET/CT findings of granulocyte colony stimulating factor (G-CSF)-producing lung tumors. Ann Nucl Med (2008) 0.92
Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis. Joint Bone Spine (2012) 0.92
Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes. Mol Cell Endocrinol (2003) 0.91
Up-regulation of c-met protooncogene product expression through hypoxia-inducible factor-1alpha is involved in trophoblast invasion under low-oxygen tension. Endocrinology (2005) 0.91
F-18 FDG PET/CT findings showing lymph node uptake in patients with Kikuchi disease. Clin Nucl Med (2009) 0.91
Estrogen inhibits paclitaxel-induced apoptosis via the phosphorylation of apoptosis signal-regulating kinase 1 in human ovarian cancer cell lines. Endocrinology (2003) 0.91
Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model. Cancer Res (2005) 0.90
In vivo evaluation of gray and white matter volume loss in the parkinsonian variant of multiple system atrophy using SPM8 plus DARTEL for VBM. Neuroimage Clin (2013) 0.90
Evaluation of sequential FDG-PET/CT for monitoring bone metastasis of breast cancer during therapy: correlation between morphological and metabolic changes with tumor markers. Ann Nucl Med (2012) 0.90
Cold tuberculous abscess identified by FDG PET. Ann Nucl Med (2005) 0.90
The effects of repeated corticosteroid administration on the neurogenesis in the neonatal rat. Am J Obstet Gynecol (2006) 0.90
Lung amyloid nodule detected by 99mTc-aprotinin scintigraphy. Ann Nucl Med (2012) 0.90
Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival. Int J Radiat Oncol Biol Phys (2011) 0.90
Triple-phase dynamic MRI of intratumoral vessel density and hyalinization grade in uterine leiomyomas. AJR Am J Roentgenol (2004) 0.89
PET/CT evaluation of the physiologic accumulation of 18F-FDG within the gallbladder vesicle. Nucl Med Biol (2007) 0.89
Post-ischemic hypothermia reduced IL-18 expression and suppressed microglial activation in the immature brain. Brain Res (2006) 0.89
NF-kappaB activation at implantation window of the mouse uterus. Am J Reprod Immunol (2004) 0.89
Involvement of nuclear factor-kB activation through RhoA/Rho-kinase pathway in LPS-induced IL-8 production in human cervical stromal cells. Mol Hum Reprod (2007) 0.89
Differentiation between completely hyalinized uterine leiomyomas and ordinary leiomyomas: three-phase dynamic magnetic resonance imaging (MRI) vs. diffusion-weighted MRI with very small b-factors. J Magn Reson Imaging (2004) 0.89
Prediction of lymphatic metastasis based on gene expression profile analysis after brachytherapy for early-stage oral tongue carcinoma. Radiother Oncol (2008) 0.88
Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMM. J Nucl Med (2013) 0.88
Altered protein expression in endometrial carcinogenesis. Cancer Lett (2005) 0.88
Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells. Gynecol Oncol (2002) 0.88
Evaluation of Wegener's granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Ann Nucl Med (2012) 0.87
4'-[Methyl-11C]-thiothymidine PET/CT for proliferation imaging in non-small cell lung cancer. J Nucl Med (2011) 0.87